Schedule 13G ownership disclosure
Trevi Therapeutics Inc
Security class unavailable · CUSIP: 89532M101
Event date: 2022-03-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 360,000
- Percent of class
- 1.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-031938
- Form type
- SC 13G
- Filer
- Oliveira Steven Michael
- CIK
- CIK 1358629
- Filed
- Mar 09, 2022
- Reporting period
- Mar 07, 2022
- Description
- Schedule 13G beneficial ownership